Supplementary data, Figure 1 from Bruton's Tyrosine Kinase Inhibitors Prevent Therapeutic Escape in Breast Cancer Cells
Year: 2023
Type: supplementary-materials
Abstract: Structures of BTK inhibitors. Ibrutinib and AVL-292 are irreversible inhibitors, covalently binding to Cys481 of BTK.
Authors: Xianhui Wang, Jason Wong, Christopher J. Sevinsky, Leila Kokabee, Faiza Khan, Yan Sun, Douglas S. Conklin
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
OpenAlex ID: W4362622402